The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

Early-stage endometrial cancer has an excellent prognosis; however, the survival rates for patients with advanced disease remain very low and an optimum management strategy has yet to be defined.

When diagnosed in the early stages, the prognosis for someone with endometrial cancer is good. The 5-year survival rate for ...

Survival for early-stage endometrial cancer remains high at more than 80%; however, survival rates for advanced uterine cancer decrease substantially. The research is published in the Journal of ...

Incidences for many common types of cancer have risen in recent years, with young women experiencing the brunt of the shift.

The risk and incidence of cancer among people under 50 is also on the rise, according to American Cancer Society.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...

Uterine cancer, which often begins in the lining—or endometrium—of the uterus, is the most common cancer of the female reproductive system and usually occurs in people over age 55. Learn more ...

The ACS predicts in 2025 there will be more than 2.04 million new cancer diagnoses and 618,120 cancer deaths. Death rates are on the rise for certain cancers: oral cavity, pancreas, uterine corpus ...

GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...